Spravato (Esketamine) in Summerville, SC
FDA-approved. Noticeable improvement within hours or days for many patients.
What a Session Looks Like
Supervised In-Clinic Administration.
Two-Hour Monitoring Period.
Spravato is self-administered as a nasal spray under direct supervision in our clinic. After dosing, you are monitored for two hours. Treatment is twice weekly for the first month, then weekly or biweekly for maintenance.
Patients may experience temporary dissociation, dizziness, or sedation — these effects resolve before you leave. You cannot drive on treatment days.
Arrive at clinic
Check in and pre-session assessment
Self-administer nasal spray
Under direct clinical supervision
2-hour monitoring
Relax while staff monitors your response
Cleared to leave
Side effects resolve before discharge — arrange a ride
Spravato requires enrollment in the FDA REMS program and must be used alongside an oral antidepressant. It is FDA-approved for adults with treatment-resistant depression who have not responded to two or more antidepressants.
- Adults with treatment-resistant depression (2+ failed trials)
- Major depressive disorder with acute suicidal ideation
- Must be used alongside an oral antidepressant
- Must enroll in FDA REMS safety program
- Comprehensive psychiatric evaluation required
Most major commercial insurers cover Spravato for patients meeting criteria — typically two or more failed antidepressant trials. Our team handles prior authorizations and REMS enrollment from start to finish.
Call us to verify your benefits before your first appointment — we will give you a clear picture of your coverage before you commit to anything.
- Most major commercial insurers accepted
- Prior authorization handled by our team
- REMS enrollment managed by our team
- Benefits verification before you begin
- Call (843) 821-2480 to check coverage
Frequently Asked Questions
Serving Summerville, Goose Creek, Ladson & Greater Charleston
Conveniently located at 204 N Cedar St, Ste 100, Summerville, SC 29483